Literature DB >> 2205851

Abnormally high expression of proteasomes in human leukemic cells.

A Kumatori1, K Tanaka, N Inamura, S Sone, T Ogura, T Matsumoto, T Tachikawa, S Shin, A Ichihara.   

Abstract

Proteasomes are eukaryotic ring-shaped or cylindrical particles with multicatalytic protease activities. To clarify the involvement of proteasomes in tumorigenesis of human blood cells, we compared their expression in human hematopoietic malignant tumor cells with that in normal peripheral blood mononuclear cells. Immunohistochemical staining showed considerably increased concentrations of proteasomes in leukemic cells from the bone marrow of patients with various types of leukemia and the predominant localization of these proteasomes in the nuclei. Moreover, enzyme immunoassay and Northern blot analysis indicated that the concentrations of proteasomes and their mRNA levels were consistently much higher in a variety of malignant human hematopoietic cell lines than in resting peripheral lymphocytes and monocytes from healthy adults. Proteasome expression was also greatly increased in normal blood mononuclear cells during blastogenic transformation induced by phytohemagglutinin; their expression increased in parallel with induction of DNA synthesis and returned to the basal level with progress of the cell cycle. Thus, abnormally high expression of proteasomes may play an important role in transformation and proliferation of blood cells and in specific functions of hematopoietic tumor cells.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2205851      PMCID: PMC54685          DOI: 10.1073/pnas.87.18.7071

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

1.  A high molecular weight protease in the cytosol of rat liver. I. Purification, enzymological properties, and tissue distribution.

Authors:  K Tanaka; K Ii; A Ichihara; L Waxman; A L Goldberg
Journal:  J Biol Chem       Date:  1986-11-15       Impact factor: 5.157

2.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

3.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

4.  Eukaryotic pre-tRNA 5' processing nuclease: copurification with a complex cylindrical particle.

Authors:  J G Castaño; R Ornberg; J G Koster; J A Tobian; M Zasloff
Journal:  Cell       Date:  1986-08-01       Impact factor: 41.582

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  A high molecular weight protease in the cytosol of rat liver. II. Properties of the purified enzyme.

Authors:  K Tanaka; T Yoshimura; A Ichihara; K Kameyama; T Takagi
Journal:  J Biol Chem       Date:  1986-11-15       Impact factor: 5.157

7.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

8.  The 22 S cylinder particles of Xenopus laevis. II. Immunological characterization and localization of their proteins in tissues and cultured cells.

Authors:  B Hügle; J A Kleinschmidt; W W Franke
Journal:  Eur J Cell Biol       Date:  1983-11       Impact factor: 4.492

9.  Donut-shaped "miniparticles" in nuclei of human and rat cells.

Authors:  N Domae; F R Harmon; R K Busch; W Spohn; C S Subrahmanyam; H Busch
Journal:  Life Sci       Date:  1982-02-01       Impact factor: 5.037

10.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

View more
  75 in total

1.  Multiple forms of protein kinase CK2 present in leukemic cells: in vitro study of its origin by proteolysis.

Authors:  J Roig; A Krehan; D Colomer; W Pyerin; E Itarte; M Plana
Journal:  Mol Cell Biochem       Date:  1999-01       Impact factor: 3.396

2.  Developmentally regulated, alternative splicing of the Rpn10 gene generates multiple forms of 26S proteasomes.

Authors:  H Kawahara; M Kasahara; A Nishiyama; K Ohsumi; T Goto; T Kishimoto; Y Saeki; H Yokosawa; N Shimbara; S Murata; T Chiba; K Suzuki; K Tanaka
Journal:  EMBO J       Date:  2000-08-01       Impact factor: 11.598

Review 3.  Prosomes (proteasomes) changes during differentiation are related to the type of inducer.

Authors:  J P Bureau; L Henry; A Baz; K Scherrer; M T Château
Journal:  Mol Biol Rep       Date:  1997-03       Impact factor: 2.316

4.  A novel proteasome interacting protein recruits the deubiquitinating enzyme UCH37 to 26S proteasomes.

Authors:  Jun Hamazaki; Shun-Ichiro Iemura; Tohru Natsume; Hideki Yashiroda; Keiji Tanaka; Shigeo Murata
Journal:  EMBO J       Date:  2006-09-21       Impact factor: 11.598

5.  Cancer stem cells don't waste their time cleaning-low proteasome activity, a marker for cancer stem cell function.

Authors:  Kristiaan J Lenos; Louis Vermeulen
Journal:  Ann Transl Med       Date:  2016-12

Review 6.  New uses for old copper-binding drugs: converting the pro-angiogenic copper to a specific cancer cell death inducer.

Authors:  Di Chen; Q Ping Dou
Journal:  Expert Opin Ther Targets       Date:  2008-06       Impact factor: 6.902

Review 7.  Proteasomes: multicatalytic proteinase complexes.

Authors:  A J Rivett
Journal:  Biochem J       Date:  1993-04-01       Impact factor: 3.857

8.  Apoptosis induction resulting from proteasome inhibition.

Authors:  K Shinohara; M Tomioka; H Nakano; S Toné; H Ito; S Kawashima
Journal:  Biochem J       Date:  1996-07-15       Impact factor: 3.857

Review 9.  Overview of proteasome inhibitor-based anti-cancer therapies: perspective on bortezomib and second generation proteasome inhibitors versus future generation inhibitors of ubiquitin-proteasome system.

Authors:  Q Ping Dou; Jeffrey A Zonder
Journal:  Curr Cancer Drug Targets       Date:  2014       Impact factor: 3.428

10.  Exosomal secretion of cytoplasmic prostate cancer xenograft-derived proteins.

Authors:  Flip H Jansen; Jeroen Krijgsveld; Angelique van Rijswijk; Gert-Jan van den Bemd; Mirella S van den Berg; Wytske M van Weerden; Rob Willemsen; Lennard J Dekker; Theo M Luider; Guido Jenster
Journal:  Mol Cell Proteomics       Date:  2009-02-09       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.